Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11998528
Non-sedating dexmedetomidine treatment regimens
granted -
US 11998565
Trace element compositions, methods of making and use
granted -
US 11998521
Use of an RXR agonist in treating drug resistant HER2+ cancers
granted -
US 11999777
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
granted -
US 11998576
Direct-fed microbials
granted -
US 11999778
VH4 antibodies and compositions comprising the same
granted -
US 11998589
PEGylated peptide amphiphile nanofibers and methods of use
granted -
US 11998513
Two-part nitric oxide generating topical compositions
granted -
US 11998557
Halogenated psilocybin derivatives and methods of using
granted -
US 11998606
Compounds and methods for selective proteolysis of glucocorticoid receptors
granted -
US 11999683
Lipocationic dendrimers and uses thereof
granted -
US 11999693
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted -
US 11999773
Anti-BCMA chimeric antigen receptors
granted -
US 12000829
Selection of patients for combination therapy
granted -
US 11999971
Stem cell derived islet differentiation
granted -
US 11999799
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted -
US 11999796
Anti-CD70 chimeric antigen receptors
granted -
US 11999750
Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
granted -
US 11999727
Compounds and methods of use
granted -
US 11999731
EGFR dimer disruptors and use of the same
granted -
US 11999720
Pyrazolylacylpyrazoline compounds and method for treating pain
granted -
US 11998604
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11998639
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 11998635
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.